ときわバイオ株式会社
1 known investors
Tokiwa Bio develops the Stealth-type RNA vector (SRV™), a non-integrating gene delivery vector that can introduce multiple or large genes into cells at high efficiency for gene therapy. The company also applies SRV™ to cell reprogramming for regenerative medicine and to biopharmaceutical manufacturing.
Investors · 1
Frequently asked questions
- What does ときわバイオ株式会社 do?
- Tokiwa Bio develops the Stealth-type RNA vector (SRV™), a non-integrating gene delivery vector that can introduce multiple or large genes into cells at high efficiency for gene therapy. The company also applies SRV™ to cell reprogramming for regenerative medicine and to biopharmaceutical manufacturing.
- Who are ときわバイオ株式会社's investors?
- ときわバイオ株式会社's investors include Kyoto University Innovation Capital.